Stocks News

LAST PRICE
296.7500
TODAY'S CHANGE (%)
Trending Down-3.8000 (-1.2643%)

Bid / Lots
290.0000/ 1
Ask / Lots
302.0000/ 1
Open / Previous Close
299.1500 / 300.5500
Day Range
Low 296.5900
High 304.3900
52 Week Range
Low 141.9750
High 304.3900
Volume
1,205,441
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- Press Release: Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results, from 17 hours ago by Dow Jones
  17 hours ago by Dow Jones
  Companies Mentioned: ALNY
  
  Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results
  CAMBRIDGE, Mass.--(BUSINESS WIRE)--October 17, 2024--
  Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the third quarter ending September 30, 2024 on Thursday, October 31, 2024, before the U.S. financial markets open.
- Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results, from 17 hours ago by Dow Jones
  17 hours ago by Dow Jones
  Companies Mentioned: ALNY
  
  Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results
  CAMBRIDGE, Mass.--(BUSINESS WIRE)--October 17, 2024--
  Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the third quarter ending September 30, 2024 on Thursday, October 31, 2024, before the U.S. financial markets open.
Oct 16, 2024
- DJ Alnylam Pharmaceuticals Initiated at Sector Outperform by Scotiabank, from 10:58AM ET on Wednesday Oct 16, 2024 by Dow Jones
  10:58AM ET on Wednesday Oct 16, 2024 by Dow Jones
  Companies Mentioned: ALNY
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ALNY/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 16, 2024 10:58 ET (14:58 GMT)
- Alnylam Submits Regulatory Application to EMA for ATTR Amyloidosis With Cardiomyopathy Treatment, from 9:52AM ET on Wednesday Oct 16, 2024 by MT Newswires
  9:52AM ET on Wednesday Oct 16, 2024 by MT Newswires
  Companies Mentioned: ALNY
  09:52 AM EDT, 10/16/2024 (MT Newswires) -- Alnylam Pharmaceuticals (ALNY) said Wednesday that it has submitted a type 2 variation to the European Medicines Agency for vutrisiran, an investigational RNA interference therapy being developed to treat t...
- Scotiabank Initiates Alnylam Pharmaceuticals at Sector Outperform With $305 Price Target, from 8:08AM ET on Wednesday Oct 16, 2024 by MT Newswires
  8:08AM ET on Wednesday Oct 16, 2024 by MT Newswires
  Companies Mentioned: ALNY
  08:08 AM EDT, 10/16/2024 (MT Newswires) -- Alnylam Pharmaceuticals (ALNY) has an average outperform rating and a price target range of $178 to $400, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic rese...

Yesterday
- DJ Novo Nordisk A/S Stock Rises Thursday, Outperforms Market, from 13 hours ago by Dow Jones
  13 hours ago by Dow Jones
  Companies Mentioned: NVO
- DJ Novo Nordisk Is Maintained at Outperform by BMO Capital, from 15 hours ago by Dow Jones
  15 hours ago by Dow Jones
  Companies Mentioned: NVO
- DJ Weight-Loss Drugs Cut Drug and Alcohol Abuse, According to New Study, from 17 hours ago by Dow Jones
  17 hours ago by Dow Jones
  Companies Mentioned: LLY, NVO
- Endo Announces Seven New Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting, from 17 hours ago by CNW Group
  17 hours ago by CNW Group
  Companies Mentioned: NDOI
- Endo Announces Seven New Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting, from 17 hours ago by PR Newswire
  17 hours ago by PR Newswire
  Companies Mentioned: NDOI
- DJ Take the Win: Rebalance Your Portfolio Before Markets Get Bumpy -- Barrons.com, from 22 hours ago by Dow Jones
  22 hours ago by Dow Jones
  Companies Mentioned: NVO, TSM
Oct 16, 2024
- Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024, from 4:15PM ET on Wednesday Oct 16, 2024 by Dow Jones
  4:15PM ET on Wednesday Oct 16, 2024 by Dow Jones
  Companies Mentioned: RPRX
- Press Release: Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024, from 4:15PM ET on Wednesday Oct 16, 2024 by Dow Jones
  4:15PM ET on Wednesday Oct 16, 2024 by Dow Jones
  Companies Mentioned: RPRX
- DJ Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market, from 12:03PM ET on Wednesday Oct 16, 2024 by Dow Jones
  12:03PM ET on Wednesday Oct 16, 2024 by Dow Jones
  Companies Mentioned: NVO
Oct 15, 2024
- Endo to Host Investor Call on Third-Quarter 2024 Financial Results, from 4:05PM ET on Tuesday Oct 15, 2024 by CNW Group
  4:05PM ET on Tuesday Oct 15, 2024 by CNW Group
  Companies Mentioned: NDOI

Alnylam Pharmaceuticals Inc
NASDAQ:ALNYUnited States

Search Criteria

Yesterday

Press Release: Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results, from 17 hours ago by Dow Jones

Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results, from 17 hours ago by Dow Jones

Oct 16, 2024

DJ Alnylam Pharmaceuticals Initiated at Sector Outperform by Scotiabank, from 10:58AM ET on Wednesday Oct 16, 2024 by Dow Jones

Alnylam Submits Regulatory Application to EMA for ATTR Amyloidosis With Cardiomyopathy Treatment, from 9:52AM ET on Wednesday Oct 16, 2024 by MT Newswires

Scotiabank Initiates Alnylam Pharmaceuticals at Sector Outperform With $305 Price Target, from 8:08AM ET on Wednesday Oct 16, 2024 by MT Newswires

Peers Headlines

Yesterday

DJ Novo Nordisk A/S Stock Rises Thursday, Outperforms Market, from 13 hours ago by Dow Jones

DJ Novo Nordisk Is Maintained at Outperform by BMO Capital, from 15 hours ago by Dow Jones

DJ Weight-Loss Drugs Cut Drug and Alcohol Abuse, According to New Study, from 17 hours ago by Dow Jones

Endo Announces Seven New Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting, from 17 hours ago by CNW Group

Endo Announces Seven New Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting, from 17 hours ago by PR Newswire

DJ Take the Win: Rebalance Your Portfolio Before Markets Get Bumpy -- Barrons.com, from 22 hours ago by Dow Jones

Oct 16, 2024

Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024, from 4:15PM ET on Wednesday Oct 16, 2024 by Dow Jones

Press Release: Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024, from 4:15PM ET on Wednesday Oct 16, 2024 by Dow Jones

DJ Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market, from 12:03PM ET on Wednesday Oct 16, 2024 by Dow Jones

Oct 15, 2024

Endo to Host Investor Call on Third-Quarter 2024 Financial Results, from 4:05PM ET on Tuesday Oct 15, 2024 by CNW Group